Citation

Barlas S. P T 2015; 40(8): 501-503.

Copyright

(Copyright © 2015, MediMedia)

DOI

unavailable

PMID

26236138

PMCID

PMC4517532

Abstract

Fear of lawsuits and customer confusion have greeted a U.S. Food and Drug Administration plan to let generic drug companies change labels quickly, without prior agency approval, when they learn of adverse effects once the generic reaches the market.

Language: en